Cover Image

Development of Novel ROCK Inhibitors via 3D-QSAR and Molecular Docking Studies: A Framework for Multi-Target Drug Design

<b>Background/Objectives:</b> Alterations in the actin cytoskeleton correlates to tumor progression and affect critical cellular processes such as adhesion, migration and invasion. Rho-associated coiled-coil-containing protein kinases (ROCK1 and ROCK2), important regulators of the actin...

Full description

Saved in:

Bibliographic Details
Main Authors:	Milan Beljkas (Author), Milos Petkovic (Author), Ana Vuletic (Author), Ana Djuric (Author), Juan Francisco Santibanez (Author), Tatjana Srdic-Rajic (Author), Katarina Nikolic (Author), Slavica Oljacic (Author)
Format:	Book
Published:	MDPI AG, 2024-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation
by: Dusan Ruzic, et al.
Published: (2022)

Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic Carcinoma
by: Nemanja Djokovic, et al.
Published: (2023)

3D-QSAR modeling and pharmacophore study of serotonin 5HT-₂A receptors antagonists
by: Antonijević Mirjana, et al.
Published: (2017)

3D-QSAR study and development of pharmacophore for serotonin 5-HT2A receptors agonists
by: Radan Milica, et al.
Published: (2017)

Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention
by: Dusan Ruzic, et al.
Published: (2022)

Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer
by: Milan Beljkas, et al.
Published: (2023)

Quinazoline analogues as cytotoxic agents; QSAR, docking, and in silico studies
by: Leila Emami, et al.
Published: (2021)

Modelling of chromatographic and electrophoretic behaviour of imidazoline and alpha adrenergic receptors ligands under different acid-base conditions
by: Slavica Oljacic, et al.
Published: (2024)

Lipoxygenase Inhibition Activity of Coumarin Derivatives-QSAR and Molecular Docking Study
by: Melita Lončarić, et al.
Published: (2020)

Molecular docking, QSAR and ADMET studies of withanolide analogs against breast cancer
by: Yadav DK, et al.
Published: (2017)

3D-QSAR and docking studies of arylmethylamine-based DPP IV inhibitors
by: Chaoyi Jiang, et al.
Published: (2012)

Benzo[g]quinazolines as antifungal against candidiasis: Screening, molecular docking, and QSAR investigations
by: Hatem A. Abuelizz, et al.
Published: (2023)

N-Phenyl Ureidobenzenesulfonate derivatives as novel anticancer agents: QSAR and Molecular docking studies
by: Masood Fereidoonnezhad, et al.
Published: (2017)

N-Phenyl Ureidobenzenesulfonate derivatives as novel anticancer agents: QSAR and Molecular docking studies
by: Masood Fereidoonnezhad, et al.
Published: (2017)

3D-QSAR and Docking Studies on Pyrimidine Derivatives of Second-Generation ALK Inhibitors
by: Gang-Long Jiang, et al.
Published: (2022)

Transfer and Multi-task Learning in QSAR Modeling: Advances and Challenges
by: Rodolfo S. Simões, et al.
Published: (2018)

DESAIN TURUNAN FENOKSIPIRIDIN SEBAGAI INHIBITOR PROTOPORFIRINOGEN OKSIDASE DENGAN QSAR DAN MOLECULAR DOCKING
by: Chandra Pratama Putra, -
Published: (2022)

QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase IIα
by: Alam S, et al.
Published: (2014)

3D-QSAR, Molecular Docking, and MD Simulations of Anthraquinone Derivatives as PGAM1 Inhibitors
by: Yuwei Wang, et al.
Published: (2021)

QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease
by: Fucheng Song, et al.
Published: (2023)

QSAR and Molecular Docking Studies on Non-Imidazole-Based Histamine H3 Receptor Antagonists
by: Maryam Hamzeh-Mivehroud, et al.
Published: (2020)

The Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity
by: Valeria Catalani, et al.
Published: (2021)

QSAR BERBASIS DESKRIPTOR GRAF DAN MOLECULAR DOCKING DARI TURUNAN FENILPIRIMIDIN SEBAGAI ANTIJAMUR S. SCLEROTIORUM
by: Tria Nurwina Novianti, -
Published: (2023)

3D,2D-QSAR study and docking of novel quinazolines as potential target drugs for osteosarcoma
by: Zheng Lian, et al.
Published: (2023)

Human papillomaviruses and cervical cancer from the perspective of the World Health Organisation initiative for cervical cancer elimination
by: Filipić Brankica, et al.
Published: (2024)

Whither QSAR?
by: John C. Dearden
Published: (2017)

QSAR, Molecular Docking and protein ligand interaction fingerprint studies of N-phenyl dichloroacetamide derivatives as anticancer agents
by: Masood Fereidoonnezhad, et al.
Published: (2016)

QSAR, Molecular Docking and protein ligand interaction fingerprint studies of N-phenyl dichloroacetamide derivatives as anticancer agents
by: Masood Fereidoonnezhad, et al.
Published: (2016)

2D-QSAR, Docking, Molecular dynamics simulations with the MM/GBSA approaches against Grave's disease and PTPN22
by: Emmanuel Israel Edache, et al.
Published: (2023)

Design and Synthesis of Aminopyrimidinyl Pyrazole Analogs as PLK1 Inhibitors Using Hybrid 3D-QSAR and Molecular Docking
by: Swapnil P. Bhujbal, et al.
Published: (2022)

QSAR modelling, molecular docking, molecular dynamic and ADMET prediction of pyrrolopyrimidine derivatives as novel Bruton's tyrosine kinase (BTK) inhibitors
by: Mourad Aloui, et al.
Published: (2024)

Alignment independent 3D-QSAR, quantum calculations and molecular docking of Mer specific tyrosine kinase inhibitors as anticancer drugs
by: Fereshteh Shiri, et al.
Published: (2016)

Integrative Approach for Designing Novel Triazole Derivatives as α-Glucosidase Inhibitors: QSAR, Molecular Docking, ADMET, and Molecular Dynamics Investigations
by: Oussama Abchir, et al.
Published: (2024)

An In Silico Study Based on QSAR and Molecular Docking and Molecular Dynamics Simulation for the Discovery of Novel Potent Inhibitor against AChE
by: Meriem Khedraoui, et al.
Published: (2024)

Exploration of 2D and 3D-QSAR analysis and docking studies for novel dihydropteridone derivatives as promising therapeutic agents targeting glioblastoma
by: Meichen Pan, et al.
Published: (2023)

Simulation studies, 3D QSAR and molecular docking on a point mutation of protein kinase B with flavonoids targeting ovarian Cancer
by: Suchitra Maheswari Ajjarapu, et al.
Published: (2021)

2D QSAR, design, docking study and ADMET of some N-aryl derivatives concerning inhibitory activity against Alzheimer disease
by: Abduljelil Ajala, et al.
Published: (2022)

In Silico Antiprotozoal Evaluation of 1,4-Naphthoquinone Derivatives against Chagas and Leishmaniasis Diseases Using QSAR, Molecular Docking, and ADME Approaches
by: Lina S. Prieto Cárdenas, et al.
Published: (2022)

New Insights into the Binding Features of F508del CFTR Potentiators: A Molecular Docking, Pharmacophore Mapping and QSAR Analysis Approach
by: Giada Righetti, et al.
Published: (2020)

Exploring molecular docking with E-pharmacophore and QSAR models to predict potent inhibitors of 14-α-demethylase protease from Moringa spp
by: Damilola Alex Omoboyowa
Published: (2022)